fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Phenobarbital

All products: general benefit

Phenobarb · DIN 00178799 · 15 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Phenobarb · DIN 00178799 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2026-09-04 · brand PMS-PHENOBARBITAL · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Tablet · route Oral · ingredients PHENOBARBITAL 15 MG · company Pharmascience inc · schedule Controlled drugs (cdsa iv)
Re-check Health Canada status and shortages (live) · Health Canada product record

Phenobarb: Formulary list price $0.08 per unit (the source does not state the unit; exact figure $0.0829). What the ministry pays, not the patient.

Ministry pays: $0.0829 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00178799)

Source record
DIN 00178799: Phenobarb Raw flags: sec3=Y Item: 282400236; group id 527; item number 1425; lccId None; manufacturer id PEN Source form: Tab; strength: 15mg Recorded listing: General benefit Source prices (unrounded): $0.0829; ministry $0.0829 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00178799 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=405
Shortage status: resolved shortage (ended March 11, 2022); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00178799
Shortage record checked October 6, 2026
Other drugs in the same formulary class (28:24 Sedatives and Hypnotics) and how they are covered

Matched class: 28:24 Sedatives and Hypnotics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: NITRAZEPAM, TEMAZEPAM Some products covered without a code (check the product listing): BUSPIRONE HYDROCHLORIDE, FLURAZEPAM, METHOTRIMEPRAZINE, TRIAZOLAM 28:24 Sedatives and Hypnotics

BUSPIRONE HYDROCHLORIDE

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 10mg · Tab

FLURAZEPAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 15mg, 30mg · Cap

METHOTRIMEPRAZINE

· 9 products · General benefit (5), Listed, not a benefit (4) · strengths: 25mg/mL, 2mg, 5mg, 25mg, 50mg · Inj Sol-1mL Pk, Tab

NITRAZEPAM

· 2 products · General benefit · strengths: 5mg, 10mg · Tab

TEMAZEPAM

· 2 products · General benefit · strengths: 15mg, 30mg · Cap

TRIAZOLAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.125mg, 0.25mg · Tab

LORAZEPAM

· 9 products · Listed, not a benefit (1), Limited Use, codes 481 (2), Off-Formulary Interchangeable, not an ODB benefit (6) · strengths: 4mg/mL, 0.5mg, 1mg, 2mg · Inj Sol (with preservative), SL Tab

MIDAZOLAM

· 3 products · Listed, not a benefit (1), Limited Use, codes 495, 496 (2) · strengths: 5mg/mL · Inj Sol (with Preservative)

ESZOPICLONE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1mg, 2mg, 3mg · Tab

ZOLPIDEM TARTRATE

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg · SL Tab

ZOPICLONE

· 40 products · Off-Formulary Interchangeable, not an ODB benefit (38), Off-Formulary Interchangeable, not an ODB benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (2) · strengths: 3.75mg, 5mg, 7.5mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 28:24
Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:12 Anticonvulsants, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS As a sedative, for the relief of anxiety, tension and apprehension. As a hypnotic, for the short-term management of insomnia. As an anticonvulsant, for the long-term treatment of generalized tonicoclonic and partial (cortical focal) seizures. As prophylaxis and treatment of febrile seizures. As an antihyperbilirubinemic, for the prevention and treatment of hyperbilirubinemia in neonates, also to lower bilirubin concentrations in patients with congenital non-hemolytic unconjugated hyperbilirubinemia or chronic intrahepatic cholestasis. https://pdf.hres.ca/dpd_pm/00085981.PDF PM date: SEP 04, 2026 Source product: PMS-PHENOBARBITAL; DIN 00178799; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.